-transparent.png){kind=logo}
The mechanism of airway eosinophilia during antigen-induced inflammation was investigated by measurement of eosinophil-active cytokines utilizing an eosinophil survival assay. In the first study, 4 patients with allergic rhinitis underwent segmental bronchoprovocation (SBP) with low, medium, and high doses of ragweed extract instilled into different bronchial subsegments; bronchoalveolar lavage (BAL) fluids were collected from each segment 12 min and 48 h after challenge. Eosinophil granule proteins and eosinophil survival activity were significantly elevated in the 48-h (late-phase) BAL fluids from these segments. Correlations were observed between the concentrations of eosinophil granule proteins and eosinophil survival activity (rs = 0.717 to 0.880, p < 0.001) in BAL fluids. Eosinophil survival activity was completely neutralized by anti-IL-5 monoclonal antibody in five of the seven 48-h samples tested representing three of the 4 patients. In the two remaining samples, eosinophil survival activity was only partially neutralized by either anti-IL-5 antibody or anti-granulocyte-macrophage colony-stimulating factor (GM-CSF) but was completely neutralized by anti-IL-5 and anti-GM-CSF in combination. Subsequently, in the second study, 10 patients with allergic rhinitis were challenged by SBP with ragweed extract. Eosinophil survival activity was significantly elevated in the 48-h BAL fluids; this activity was partially neutralized by anti-IL-5 antibody about (48%) and completely neutralized by the combination of anti-IL-5 and anti-GM-CSF antibodies. These findings suggest that the eosinophil survival activity in the late inflammatory lesions following SBP with allergen is mainly associated with IL-5, with small contributions from GM-CSF.(ABSTRACT TRUNCATED AT 250 WORDS)
T Ohnishi, and
H Kita, and
D Weiler, and
S Sur, and
J B Sedgwick, and
W J Calhoun, and
W W Busse, and
J S Abrams, and
G J Gleich
June 1996,
The British journal of dermatology,
T Ohnishi, and
H Kita, and
D Weiler, and
S Sur, and
J B Sedgwick, and
W J Calhoun, and
W W Busse, and
J S Abrams, and
G J Gleich
November 1992,
Journal of leukocyte biology,
T Ohnishi, and
H Kita, and
D Weiler, and
S Sur, and
J B Sedgwick, and
W J Calhoun, and
W W Busse, and
J S Abrams, and
G J Gleich
May 1995,
American journal of respiratory and critical care medicine,
T Ohnishi, and
H Kita, and
D Weiler, and
S Sur, and
J B Sedgwick, and
W J Calhoun, and
W W Busse, and
J S Abrams, and
G J Gleich
December 2011,
Diabetes,
T Ohnishi, and
H Kita, and
D Weiler, and
S Sur, and
J B Sedgwick, and
W J Calhoun, and
W W Busse, and
J S Abrams, and
G J Gleich
February 1999,
Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae,
T Ohnishi, and
H Kita, and
D Weiler, and
S Sur, and
J B Sedgwick, and
W J Calhoun, and
W W Busse, and
J S Abrams, and
G J Gleich
November 2016,
Journal of immunology (Baltimore, Md. : 1950),
T Ohnishi, and
H Kita, and
D Weiler, and
S Sur, and
J B Sedgwick, and
W J Calhoun, and
W W Busse, and
J S Abrams, and
G J Gleich
October 2014,
Journal of immunology (Baltimore, Md. : 1950),
T Ohnishi, and
H Kita, and
D Weiler, and
S Sur, and
J B Sedgwick, and
W J Calhoun, and
W W Busse, and
J S Abrams, and
G J Gleich
January 2021,
Cells,
T Ohnishi, and
H Kita, and
D Weiler, and
S Sur, and
J B Sedgwick, and
W J Calhoun, and
W W Busse, and
J S Abrams, and
G J Gleich
August 1999,
The Journal of clinical investigation,
T Ohnishi, and
H Kita, and
D Weiler, and
S Sur, and
J B Sedgwick, and
W J Calhoun, and
W W Busse, and
J S Abrams, and
G J Gleich
September 2000,
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology,
